Sandoz submits generic obesity drug applications to FDA
Go back to Sandoz submits generic obesity drug applications to FDA| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1115.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1115.70 | 52 Week Low | $67.88 | |||
| Day High | $1115.70 | P/E | 258.26 | |||
| Day Low | $1115.70 | EPS | $4.32 | |||
| Volume | 22,590 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.07 | 52 Week High | $59.00 | |||
| Open | $43.07 | 52 Week Low | $32.80 | |||
| Day High | $43.07 | P/E | N/A | |||
| Day Low | $43.07 | EPS | $0.00 | |||
| Volume | 209,011 | |||||
| (AMEX: SDZNY) | Delayed: 81.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.82 | 52 Week High | $ | |||
| Open | $81.82 | 52 Week Low | $ | |||
| Day High | $81.82 | P/E | N/A | |||
| Day Low | $81.82 | EPS | $ | |||
| Volume | 4 | |||||

